MedTrace Logo

Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy

NCT06627348 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-10-04

No results posted yet for this study

Summary

Prospective study of hilotherapy of hands and feet as prevention of chemotherapy-induced peripheral polyneuropathy induced by Taxan-based chemotherapy regimen that are used in the therapy of breast cancer and genital malignoma of the women.

Conditions

  • Equipment and Supplies

Interventions

DEVICE

Hilotherm ChemoCare

Hilotherapy

Sponsors & Collaborators

  • Hilotherm

    collaborator UNKNOWN

  • University of Ulm

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-17
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06627348 on ClinicalTrials.gov